NCT03376620View on ClinicalTrials.gov

Role of Topical Putrescine (Fibrostat) for Prevention of Hypertrophic Scars in Mammoplasty Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 2, 2011

Primary Completion Date

August 13, 2013

Study Completion Date

July 15, 2016

Conditions
Hypertrophic Scar
Interventions
DRUG

1,4-Diaminobutane

Daily application to surgical breast scars of 1,4 diaminobutane on the active side

DRUG

10% Urea cream

Daily application to surgical breast scars of 10% Urea cream on the sham side

All Listed Sponsors
lead

University of Manitoba

OTHER

NCT03376620 - Role of Topical Putrescine (Fibrostat) for Prevention of Hypertrophic Scars in Mammoplasty Patients | Biotech Hunter | Biotech Hunter